Many people think about exercise, healthy food, and mental activities when trying to protect their brains as they get older. However, scientists are beginning to discover that another everyday factor may also matter: sunlight and bright daytime exposure. Dementia affects memory, thinking, and behavior. As the condition progresses, it can interfere with a person’s ability […]

The post This Simple Habit May Lower Your Dementia Risk appeared first on Knowridge Science Report.

Most people rarely think about their sense of smell or taste. The smell of fresh coffee, the taste of a favorite family recipe, or the scent of flowers are such ordinary experiences that they often go unnoticed. It is only when these senses disappear that many people realize how important they are. A new study […]

The post Losing Sense of Smell and Taste Can Be as Devastating as Parkinson’s and stroke appeared first on Knowridge Science Report.

A major study found that common dementia risks may have a much stronger impact on women’s brains than previously recognized. Women may not only experience some dementia risk factors more often than men, but those risk factors may also have a stronger effect on their cognitive health, according to new research from the University of [...]

Dementia is one of the fastest-growing health challenges in the world. Millions of people are currently living with the condition, and the number is expected to rise sharply as populations continue to age. Dementia is not a single disease. Instead, it is a group of conditions that gradually damage memory, thinking, language, and the ability […]

The post Could More Daylight Help Lower Dementia Risk? appeared first on Knowridge Science Report.

Compound 10 slowed dementia-like decline in mice.

other factors that may have contributed to the findings. The study findings are promising because they point to a widely available intervention that may offer benefits beyond preventing shingles. However, caution is still needed. More research, including carefully designed clinical trials, is necessary before doctors can conclude that the vaccine directly protects against dementia. Even […]

The post Common Shingles Vaccine Could Help Protect the Brain from Dementia appeared first on Knowridge Science Report.

A groundbreaking study led by researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute has unveiled critical nuances in how amyloid pathology correlates with cognitive impairment and genetic risk factors across diverse populations. By leveraging advanced neuroimaging datasets from over 17,000 participants, including a substantial subset of Hispanic individuals, the team shed light on population-specific differences in Alzheimer’s disease biology that challenge prevailing assumptions. Their findings, recently published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, underscore the importance of inclusive research approaches for unraveling Alzheimer’s heterogeneity and guiding precision therapeutics.

Amyloid-beta protein accumulation in the brain, manifesting as plaques, is a hallmark pathological feature of Alzheimer’s disease. Traditionally, the burden of amyloid deposition has been closely linked to clinical symptoms of cognitive decline and to the presence of the APOE ε4 allele—a potent genetic risk factor for late-onset Alzheimer’s. However, the USC-led study reveals that these relationships manifest differently in Hispanic populations compared to non-Hispanic whites. Despite having cognitive impairment or carrying APOE ε4, Hispanic participants generally showed lower amyloid levels, suggesting alternative or additional mechanisms may contribute to dementia risk and progression in this group.

Central to this study’s success was the innovative use of the Global Alzheimer’s Association Interactive Network (GAAIN), a powerful data-sharing platform developed at Stevens INI. GAAIN enables researchers worldwide to harmonize and analyze large-scale Alzheimer’s datasets, overcoming longstanding barriers posed by heterogeneity in imaging technology, tracers, and data acquisition methods. The platform facilitated the integration of amyloid PET imaging data standardized using the Centiloid scale—an analytical tool designed to normalize amyloid burden measurements across different scanners and imaging protocols—allowing for unprecedented cross-cohort comparisons.

The research consortium amalgamated data from five prominent sources, including the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease study, the Alzheimer’s Disease Neuroimaging Initiative, and the Health and Aging Brain Study–Health Disparities among others. This meta-analytic approach enabled comprehensive examination of amyloid burden across a racially and ethnically diverse sample, encompassing a wide clinical spectrum from normal cognition to dementia. The depth and breadth of this database allowed for refined statistical analyses that accounted for confounding factors such as age, sex, level of education, and cognitive performance.

Investigators utilized the Centiloid scale as a unifying metric to quantitatively assess amyloid load. This scale transforms heterogeneous imaging data into standardized units, facilitating direct comparisons across multi-site studies that previously lacked uniformity. By employing such quantitative rigor, the team demonstrated that while amyloid positivity correlated strongly with cognitive impairment overall, Hispanic individuals displayed a distinct profile characterized by comparatively lower amyloid deposition at equivalent levels of cognitive deficit, even when carrying the APOE ε4 allele.

Genetic analyses further illuminated the complexity of disease risk. Although APOE ε4 status increased amyloid positivity in both Hispanic and non-Hispanic white participants, the strength of this association was markedly attenuated in Hispanic cohorts. Specifically, non-Hispanic white carriers had over a fourfold increased likelihood of amyloid pathology, whereas this risk was approximately two and a half times in Hispanic carriers. These differential risks suggest that genetic and environmental contexts modulate Alzheimer’s pathophysiology in a population-specific manner.

Importantly, the study cautions against simplistic interpretations that lower amyloid levels imply lower dementia risk in Hispanic populations. In fact, epidemiological data shows that Hispanic adults experience a disproportionate burden of dementia. The researchers propose that the pathogenesis in these populations may be driven by a confluence of factors beyond amyloid accumulation, including vascular comorbidities, social determinants of health, and potentially other as-yet-unidentified biological processes. This underscores the need for multi-dimensional investigative frameworks.

As anti-amyloid therapies emerge as frontline interventions in Alzheimer’s management, understanding population-level variability in amyloid pathology is paramount. Treatments targeting amyloid may yield differential efficacy, and precision medicine approaches must account for the heterogeneity elucidated by this study. Tailoring interventions based on nuanced biomarker profiles and genetic backgrounds could enhance therapeutic outcomes and equity in clinical care.

The study authors emphasize the necessity for further research with larger, more detailed Hispanic cohorts. Granular data on Hispanic ancestry and longitudinal follow-up will be critical to decipher the dynamics of amyloid deposition and cognitive decline. Additionally, incorporating assessments of vascular health and other metabolic factors may clarify contributors to the divergent amyloid-cognition relationships observed.

Stevens INI director Arthur W. Toga highlights the transformative potential of open data platforms like GAAIN for accelerating Alzheimer’s research across historically underrepresented populations. By fostering collaboration and data integration, these resources enable scientists to capture the biological complexity of dementia and propel the development of innovative, inclusive treatment paradigms.

In summary, this extensive meta-analysis not only challenges conventional paradigms regarding amyloid pathology and genetic risk in Alzheimer’s disease but also advocates for a broader, more inclusive scientific lens. As the global population ages and diversifies, such insights will be essential to addressing the multifaceted challenges of dementia care and research.

Subject of Research: People
Article Title: Association of cognitive impairment and APOE ε4 with Centiloids in Hispanic and non-Hispanic White cohorts
News Publication Date: 11-Jun-2026
Web References: https://ini.usc.edu, https://gaain.org
References: Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, DOI: 10.1002/alz.71586
Image Credits: Stevens INI
Keywords: Alzheimer disease, Neuroscience, Genetics, Aging populations

Postoperative delirium is a common but often overlooked complication that affects many older adults after surgery. It can cause sudden confusion, trouble paying attention, memory problems, and changes in awareness. Some people may become agitated and restless, while others become unusually quiet and withdrawn. These symptoms can appear within hours or days after an operation […]

The post Common Surgery Complication May Speed Up Memory Decline for Years appeared first on Knowridge Science Report.

For many years, scientists have searched for the causes of Alzheimer’s disease. Most attention has focused on abnormal protein deposits that build up inside the brain. These protein clumps are considered one of the main signs of the disease. However, a new study suggests that another process may also be involved, and it comes from […]

The post Could Alzheimer’s Disease Start With Mutated Immune Cells? New Research Reveals an Unexpected Clue appeared first on Knowridge Science Report.

Over the past few decades, HIV has changed from a deadly disease into a manageable long-term condition for many people. Modern treatments can suppress the virus so effectively that patients often live for many decades after diagnosis. As a result, researchers are increasingly focused on understanding the long-term health challenges that remain, including problems that […]

The post Flu Drugs Show Promise Against Cognitive Decline appeared first on Knowridge Science Report.

Scientists found a concerning Alzheimer’s link involving glucosamine, a joint supplement used by millions. A widely used supplement marketed for joint pain relief may be linked to faster progression of Alzheimer’s disease, according to new research from University of Florida scientists. The study found that people with mild cognitive impairment (MCI) who reported taking glucosamine [...]

Millions of people take glucosamine every day in the hope of reducing joint pain and maintaining mobility as they age. The supplement has long been marketed as a natural way to support joint health, particularly for people with osteoarthritis. Because it is sold over the counter and does not require a prescription, many consumers assume […]

The post Could a Popular Joint Supplement Increase Alzheimer’s Risk? appeared first on Knowridge Science Report.

Alzheimer’s disease is the most common cause of dementia, affecting millions of people worldwide. It gradually damages brain cells, leading to memory loss, confusion, difficulty with daily activities, and changes in thinking and behavior. As populations continue to age, the number of people living with Alzheimer’s is expected to rise sharply in the coming decades, […]

The post Simple Blood Test Could Help Doctors Detect and Track Alzheimer’s Disease appeared first on Knowridge Science Report.

Tiny lab-grown brain models and the particles they release may reveal hidden differences among Alzheimer’s patients. Personalized treatment remains one of the biggest challenges in Alzheimer’s disease. Two patients can receive the same medication for symptoms such as depression, anxiety, or agitation and experience very different outcomes, leaving doctors with few ways to predict who [...]

Growing evidence suggests that sleep may play a major role in protecting the brain as we get older. Scientists have known for years that poor sleep is linked to memory problems, difficulty concentrating, and a higher risk of dementia. Now, a new study from the University of Arizona suggests that several common sleep habits may […]

The post Three Common Sleep Habits Linked to Faster Brain Aging appeared first on Knowridge Science Report.

As people grow older, many changes occur in the body. Vision may become weaker, joints may become stiffer, and hearing often becomes less sharp. For decades, hearing loss was largely considered a quality-of-life issue that made conversations more difficult. Today, scientists are beginning to view it very differently. New research from the University of Hong […]

The post A Simple Device May Help Prevent Dementia appeared first on Knowridge Science Report.

Millions of older adults around the world live with hearing loss. Many see it as an annoying part of getting older, something that makes conversations harder or requires turning up the television volume. However, scientists are increasingly discovering that hearing loss may affect much more than hearing alone. It may also play an important role […]

The post Large Global Study Links Hearing Aids to Lower Dementia Risk appeared first on Knowridge Science Report.

A new study suggests that subtle changes in the brain’s immune cells could help explain why some people remain mentally sharp despite Alzheimer’s pathology. For decades, Alzheimer’s research has focused on the buildup of amyloid plaques and tau tangles, the two hallmark features of the disease. Yet a puzzling reality has continued to challenge scientists: [...]

Scientists have uncovered an early brain mechanism that may help explain why people carrying the APOE4 gene face a higher risk of Alzheimer’s disease. For millions of people who carry the APOE4 gene, the strongest known genetic risk factor for Alzheimer’s disease, changes in brain activity may start years before memory problems become noticeable. Researchers [...]

A new study shows that tau helps organize and preserve long-term memories, while abnormal tau may contribute to memory problems in Alzheimer’s disease by disrupting memory formation and recall. New research has revealed that tau, a protein closely linked to Alzheimer’s disease, is also essential for creating long-lasting memories. The findings could point to new [...]